Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biosensors fends off Angiotech, Boston Scientific

This article was originally published in The Gray Sheet

Executive Summary

Production and distribution of the Axxion drug-eluting stent continues in Europe after Biosensors prevails in a patent dispute brought by Angiotech and Boston Scientific. Biosensors' stent originally was cleared for sale in Europe in July 2005, but the firm was sued in December 2005. Angiotech and Boston Scientific claimed the device infringed a patent describing the use of paclitaxel and a polymeric coating on a stent. The news could be heartening to stent manufacturer Conor Medsystems, which is also embroiled in litigation in the Netherlands against Angiotech and Boston Scientific over the same patent (1"The Gray Sheet" Feb. 7, 2005, p. 7)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT023174

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel